By / October 16, 2019

Medicinal cannabis in the European Union has been approved

For the first time in history, cannabis in the European Union has been approved for medical use.

Medicinal cannabis in the European Union will be allowed

The EU made this decision after several countries on the continent legalized cannabis for medical use. This includes the United Kingdom, Germany, and Italy.

Meanwhile, the Food and Drug Administration approved cannabis in the United States last June.

“We are convinced that patients and doctors deserve access to well-tested and evaluated cannabis-based medicine produced to the highest standards and approved by drug regulators,” said GW Pharmaceutical CEO, Justin Gower.

The two forms of epilepsy that will be treated with cannabis (called Dravet’s syndrome and Lennox-Gusteau’s syndrome) begin in childhood and cause multiple seizures during the day. This increases the risk of falls and injuries in patients.

They are resistant to existing antiepileptic drugs. Epidiolex has been approved for use in addition to the old antiepileptic drug Clobazam.

Cannabis in the European Union to be legalized for medicinal use
EU doctors can prescribe Epidyolex by GW Pharmaceuticals Plc to alleviate attacks. (Source)

Medicinal cannabis in Europe

Over two years have passed since the German parliament voted to legalize medicinal cannabis. This was a landmark result in Europe considering that cannabis was still a strong narcotic in many countries at the time.

Since then, many other European states have followed in Germany’s footsteps. Now even the European Commission has a connection with this process.

The legalization of medical cannabis has a profound benefit for patients with severe diseases, such as multiple sclerosis or epilepsy.

However, it also comes with complex decisions regarding the import, export, and cultivation of cannabis plants. These have to be made and monitored by the appointed regulatory body.

Cannabis cultivation in Germany

In Germany, the process for cultivation licenses had several hiccups. Although import licenses had to span the duration of the tender process, the country encountered severe supply bottlenecks.

The tender process has since experienced a makeover and now, after two years, the licensees have been named.

All in all, a lot has been happening in regard to the legalization of medicinal cannabis in Europe.

Legal cannabis in the European Union gives alternatives to pharmaceutical medicine.
Malta has implemented some new laws and now allows the licensed growing and export of cannabis to other European countries. (Source)

Legal cannabis in the European Union is inspired by Germany and other EU countries

There have also been some significant developments regarding medicinal cannabis in other European countries.

For example, Poland has implemented a domestic cannabis law allowing the import of medical cannabis products. This was a big step forward and these products are now available on the shelves of Polish pharmacies.

As a result, some of the popular licensed producers in Canada have stepped into the Polish market as well.

There have also been some developments in Malta. Although it is not the largest European country, from a climate point of view, it’s definitely interesting to grow cannabis there.

Malta has implemented some new laws and now allows licensed growing and exporting of legal cannabis in the European Union to other EU countries.

From a legal point of view, the advantage is that the legislation in Malta fully adheres to the 1961 Single Convention on Narcotic Drugs, which is a very important step.

Also, the certification Malta has is an EU Goods Manufacturing Practice (GMP) certification, which means that importers don’t have to get their certification additionally approved by the German authorities.

All European member states recognize one GBP certification within the European Union.

(Featured image by Sara Kurfeß)

First published in ubr, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Comments are closed for this post.